These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24857576)

  • 1. Medical therapy for advanced forms of thyroid cancer.
    Rajhbeharrysingh U; Taylor M; Milas M
    Surg Clin North Am; 2014 Jun; 94(3):541-71. PubMed ID: 24857576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic advances in the management of progressive thyroid cancer.
    Woyach JA; Shah MH
    Endocr Relat Cancer; 2009 Sep; 16(3):715-31. PubMed ID: 19218279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.
    Kojic KL; Kojic SL; Wiseman SM
    Expert Rev Anticancer Ther; 2012 Mar; 12(3):345-57. PubMed ID: 22369326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on thyroid cancer treatment.
    Regalbuto C; Frasca F; Pellegriti G; Malandrino P; Marturano I; Di Carlo I; Pezzino V
    Future Oncol; 2012 Oct; 8(10):1331-48. PubMed ID: 23130931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary, anaplastic, and metastatic cancers of the thyroid.
    Pitt SC; Moley JF
    Semin Oncol; 2010 Dec; 37(6):567-79. PubMed ID: 21167376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of external beam radiation and targeted therapy in thyroid cancer.
    Brierley J; Sherman E
    Semin Radiat Oncol; 2012 Jul; 22(3):254-62. PubMed ID: 22687950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy in thyroid cancer.
    Nixon IJ; Shaha AR; Tuttle MR
    Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):130-4. PubMed ID: 23435040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on clinical trials of targeted therapies in thyroid cancer.
    Haraldsdottir S; Shah MH
    Curr Opin Oncol; 2014 Jan; 26(1):36-44. PubMed ID: 24240178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated thyroid cancer.
    Burns WR; Zeiger MA
    Semin Oncol; 2010 Dec; 37(6):557-66. PubMed ID: 21167375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies in advanced differentiated thyroid cancer.
    Carneiro RM; Carneiro BA; Agulnik M; Kopp PA; Giles FJ
    Cancer Treat Rev; 2015 Sep; 41(8):690-8. PubMed ID: 26105190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.
    Lalami Y; Awada A
    Curr Opin Oncol; 2011 May; 23(3):235-40. PubMed ID: 21330922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy for thyroid cancer: An updated review of investigational agents.
    Deshpande HA; Gettinger SN; Sosa JA
    Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma.
    Brose MS; Smit J; Capdevila J; Elisei R; Nutting C; Pitoia F; Robinson B; Schlumberger M; Shong YK; Takami H
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1137-47. PubMed ID: 23098114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research.
    Sarlis NJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):103-15. PubMed ID: 12476792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current progress and management in molecular targeted therapy for advanced thyroid cancer].
    Okamura R; Sugitani I
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):148-52. PubMed ID: 24743192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of thyroid tumor aggressiveness.
    Clark OH
    West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target therapies for radioiodine refractory advanced thyroid tumors.
    Schlumberger M
    J Endocrinol Invest; 2012; 35(6 Suppl):40-4. PubMed ID: 23014073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease.
    O'Neill JP; O'Neill B; Condron C; Walsh M; Bouchier-Hayes D
    J Laryngol Otol; 2005 Aug; 119(8):585-91. PubMed ID: 16102210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.